Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)
China flag China · Delayed Price · Currency is CNY
7.02
-0.01 (-0.14%)
Feb 3, 2026, 3:04 PM CST

SHE:000908 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
26.1485.5213.17181.39172.18164.2
Cash & Short-Term Investments
26.1485.5213.17181.39172.18164.2
Cash Growth
20.77%549.63%-92.74%5.35%4.86%-69.34%
Accounts Receivable
70.6670.1385.92197.02217.24465.31
Other Receivables
142.871231.9527.1691.2284.43
Receivables
213.5282.13117.86224.18308.46549.74
Inventory
51.2644.1864.58120.37155.4232.39
Other Current Assets
16.2215.3618.1545.3541.4875.55
Total Current Assets
307.14227.19213.76571.3677.511,022
Property, Plant & Equipment
318.88328.67434.21553.48726.11,014
Long-Term Investments
73.1542.7844.7250.46103.86166.77
Goodwill
-0.120.1233.0333.0371.98
Other Intangible Assets
72.1453.4561.55101.66100.4794.62
Long-Term Deferred Tax Assets
2.012.4910.4130.323.5764.34
Long-Term Deferred Charges
97.97111.12107.86106.49117.4253.76
Other Long-Term Assets
6.69174.17187.7210.8210.362.85
Total Assets
877.99939.981,0601,4581,7922,690
Accounts Payable
91.74102.96148.94138.54122.97186.25
Accrued Expenses
20.553.45105.76109.5163.2919.1
Short-Term Debt
9.75191.67195.82213.02475.67940
Current Portion of Long-Term Debt
261.92260.9299.42299.8387.68388.18
Current Portion of Leases
-11.463.673.631.3-
Current Income Taxes Payable
30.322.460.624.931.171.25
Current Unearned Revenue
14.9516.2824.1926.225.2222.07
Other Current Liabilities
358.74265.56263.12287.71283.8301.81
Total Current Liabilities
787.92904.731,0421,0831,3611,859
Long-Term Debt
--72.2872.521-
Long-Term Leases
7.16.7122.699.847.87-
Long-Term Unearned Revenue
14.4717.1520.7324.8151.01124.17
Long-Term Deferred Tax Liabilities
2.852.917.76.455.278.86
Other Long-Term Liabilities
103.423.6170.0458.9338.3460.14
Total Liabilities
915.74955.111,2351,2561,4652,052
Common Stock
416.69416.69416.69416.69416.69416.69
Additional Paid-In Capital
617.75617.75617.75617.75617.42647.53
Retained Earnings
-978.56-933.99-1,086-850.2-708.89-545.23
Comprehensive Income & Other
-18.58-18.65-18.59-19.46-18.831.04
Total Common Equity
37.381.8-70.45164.79306.39520.03
Minority Interest
-75.05-96.93-104.1936.8521.34118.15
Shareholders' Equity
-37.76-15.13-174.64201.63327.73638.18
Total Liabilities & Equity
877.99939.981,0601,4581,7922,690
Total Debt
278.77470.74593.88598.81873.521,328
Net Cash (Debt)
-252.63-385.22-580.72-417.42-701.35-1,164
Net Cash Per Share
-0.29-0.44-0.66-0.47-0.80-1.32
Filing Date Shares Outstanding
876.57879.77879.77879.77879.77879.77
Total Common Shares Outstanding
876.57879.77879.77879.77879.77879.77
Working Capital
-480.78-677.54-827.79-512.06-683.57-836.79
Book Value Per Share
0.040.09-0.080.190.350.59
Tangible Book Value
-34.8428.23-132.1230.1172.89353.44
Tangible Book Value Per Share
-0.040.03-0.150.030.200.40
Buildings
-267.57337.65401.86527.56677.09
Machinery
-280.5291.5412.21385.78570.1
Construction In Progress
-70.2270.2288.3787.7282.61
Source: S&P Global Market Intelligence. Standard template. Financial Sources.